Cargando…
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study
BACKGROUND: CDK4/6 inhibitors combined with endocrine therapy have significantly improved treatment outcomes for metastatic hormone receptor-positive (HR+) breast cancer patients. However, the impact of low HER2 expression on treatment response and progression-free survival (PFS) remains unclear. ME...
Autores principales: | Caliskan Yildirim, Eda, Atag, Elif, Coban, Ezgi, Umit Unal, Olcun, Celebi, Abdussamet, Keser, Murat, Uzun, Mehmet, Keskinkilic, Merve, Tanrikulu Simsek, Eda, Sari, Murat, Yavuzsen, Tugba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382953/ https://www.ncbi.nlm.nih.gov/pubmed/37343321 http://dx.doi.org/10.1016/j.breast.2023.06.006 |
Ejemplares similares
-
Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study
por: Yıldırım, Hasan Çağrı, et al.
Publicado: (2022) -
What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical?
por: Salih Semiz, Huseyin, et al.
Publicado: (2022) -
Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.
por: Tanrıkulu Şimşek, Eda, et al.
Publicado: (2022) -
Nephrogenic Syndrome of Inappropriate Antidiuresis Mimicking Hyporeninemic Hypoaldosteronism: Case Report of Two Infants
por: Mammadova, Jamala, et al.
Publicado: (2023) -
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
por: Karacin, Cengiz, et al.
Publicado: (2023)